These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1243822)

  • 1. The treatment of psoriasis with azaribine.
    Deneau DG; Farber EM
    Dermatologica; 1975; 151(3):158-63. PubMed ID: 1243822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azaribine (Triazure) for severe psoriasis.
    Med Lett Drugs Ther; 1976 Jan; 18(2):7-8. PubMed ID: 1107792
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind controlled crossover high-dose study of Azaribine in psoriasis.
    Crutcher WA; Moschella SL
    Br J Dermatol; 1975 Feb; 92(2):199-205. PubMed ID: 1096923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriatic arthritis with azaribine.
    Levine S; Paulus HE
    Arthritis Rheum; 1976; 19(1):21-8. PubMed ID: 766762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for use of azaribine in treatment of psoriasis.
    Arch Dermatol; 1976 Mar; 112(3):388-90. PubMed ID: 946586
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia of azaribine in the treatment of psoriasis.
    Cornell RC; Milstein HG; Fox RM; Stoughton RB
    Arch Dermatol; 1976 Dec; 112(12):1717-23. PubMed ID: 1036874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azaribine therapy for psoriasis. Evaluation of potential effects on the liver and other organ systems.
    Keefer RA; Roenigk HH; Hawk WA
    Arch Dermatol; 1975 Jul; 111(7):853-6. PubMed ID: 1173747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies of neurotoxicity in patients with psoriasis treated with azaribine, utilizing high-pressure liquid chromatography.
    Doolittle CH; McDonald CJ; Calabresi P
    J Lab Clin Med; 1977 Nov; 90(5):773-85. PubMed ID: 578521
    [No Abstract]   [Full Text] [Related]  

  • 9. Low dose azaribine in the treatment of psoriasis.
    Dantzig PI; McEvoy B; Mauro J; Rayhanzadeh S
    Br J Dermatol; 1974 Nov; 91(5):573-7. PubMed ID: 4611468
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationally designed combination chemotherapy for the treatment of patients with recalcitrant psoriasis.
    Alper JC; Wiemann MC; Rueckl FS; McDonald CJ; Calabresi P
    J Am Acad Dermatol; 1985 Oct; 13(4):567-77. PubMed ID: 2416788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azaribine in the treatment of psoriasis. A low dose, double-blind evaluation.
    Milstein HG; Cornell RC; Stoughton RB
    Arch Dermatol; 1973 Jul; 108(1):43-7. PubMed ID: 4577493
    [No Abstract]   [Full Text] [Related]  

  • 12. Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods.
    Raab W; Gmeiner B; Muckenhuber P
    Arch Dermatol Res (1975); 1977 Dec; 260(3):257-9. PubMed ID: 203231
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of psoriasis.
    McDonald CJ
    Int J Dermatol; 1975 Oct; 14(8):563-74. PubMed ID: 1100544
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of psoriasis: ten years of experience.
    Moschella SL
    Int J Dermatol; 1976 Jun; 15(5):373-8. PubMed ID: 946966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic chemotherapy for psoriasis: a national survey.
    Bergstresser PR; Schreiber SH; Weinstein GD
    Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Thrombosis and psoriasis.
    Burton JL; Matthews CN
    Lancet; 1976 Jan; 1(7953):257. PubMed ID: 55572
    [No Abstract]   [Full Text] [Related]  

  • 17. Triazure and public drug policies.
    Shubin S
    Perspect Biol Med; 1979; 22(2 Pt 1):185-204. PubMed ID: 582335
    [No Abstract]   [Full Text] [Related]  

  • 18. New indications for 6-azauridine treatment in man. A review.
    Elis J; Rasková H
    Eur J Clin Pharmacol; 1972 Mar; 4(2):77-81. PubMed ID: 4570456
    [No Abstract]   [Full Text] [Related]  

  • 19. The uses of systemic chemotherapeutic agents in psoriasis.
    McDonald CJ
    Pharmacol Ther; 1981; 14(1):1-24. PubMed ID: 7033998
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody response in psoriatic patients treated with 6-azauridine-triacetate.
    Perlík F; Elis J; Kubíková M
    Eur J Clin Pharmacol; 1973 Aug; 6(2):141-3. PubMed ID: 4769697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.